Northwestern Mutual Wealth Management’s Standard BioTools LAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-30,703
Closed -$28.2K 4298
2026
Q1
$28.2K Buy
+30,703
New +$37.2K ﹤0.01% 2672
2015
Q3
Sell
-1
Closed 1761
2015
Q2
$0 Buy
+1
New +$32 ﹤0.01% 1535

Other funds holding LAB

Northwestern Mutual Wealth Management's LAB Position: Q2 2026 in Review

Northwestern Mutual Wealth Management sold out of Standard BioTools (LAB) in Q2 2026, closing a stake of 30,703 shares — an estimated $28.2K sold.

Northwestern Mutual Wealth Management first reported a position in LAB in Q2 2015 and held it in 2 quarters. The position peaked at $28.2K in Q1 2026. 143 funds tracked by Wall St. Rank hold LAB as of Q2 2026.

  • Northwestern Mutual Wealth Management reported no remaining Standard BioTools position as of Q2 2026 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 30,703 Standard BioTools shares in Q2 2026, an estimated $28.2K.
  • Northwestern Mutual Wealth Management first reported a position in Standard BioTools in Q2 2015 and held it in 2 quarters.
  • Northwestern Mutual Wealth Management's Standard BioTools position peaked at $28.2K in Q1 2026.
  • 143 funds tracked by Wall St. Rank held Standard BioTools as of Q2 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.